GET THE APP

Evaluation of Pulmonary Artery Pressure during Percutaneous | 52093
International Research Journals

International Research Journal of Biochemistry and Bioinformatics

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Evaluation of Pulmonary Artery Pressure during Percutaneous Transvenous Mitral Commissurotomy in Rheumatic Mitral Stenosis

Abstract

Ananda G.C*

Rheumatic heart disease is one of the most common heart diseases in developing country. One of the most common complications of Rheumatic Heart Disease is Mitral Stenosis which ultimately lead to pulmonary hypertension and heart failure and death. So, PTMC (Percutaneous Transluminal Mitral Commissurotomy) is a well-established simple, effective and safe therapeutic intervention for mitral stenosis. While many literatures reviewed till date have shown that it takes 3-6 months time period for the reduction of pulmonary artery pressure after PTMC, this study is designed to see the result in pulmonary artery pressure immediately after procedure.

Share this article